Atriance 50ml (Nelarabine Vials) 5mg/mlx50ml

Atriance 50ml (Nelarabine) is an antineoplastic agent used in cancer treatment. This 50ml vial contains 5mg/ml of nelarabine for intravenous administration. It is prescribed under medical supervision for specific oncology indications. Store in a controlled environment as directed.

Strength

5mg/mlx50ml

Manufacturer / TM Owner

Sandoz Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nelarabine is primarily used to treat certain types of cancer, including T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. It belongs to a class of medications called antimetabolites, which interfere with the growth of cancer cells. Patients may wonder, 'what is nelarabine used for' or 'nelarabine 5mg/ml uses' when discussing treatment options with healthcare providers.

Side Effects

Nelarabine works by disrupting the replication of cancer cells, helping to slow or stop their spread. Common effects may include changes in blood cell counts, fatigue, or gastrointestinal discomfort. Individual responses vary, and these effects are typically monitored by a healthcare professional.

Precautions & Warnings

This medication should only be handled and administered by trained medical personnel. Patients should disclose all current medications, including over-the-counter and herbal products, to avoid potential complications. Regular blood tests are often required to monitor treatment progress and safety.

Avoid Interactions

Nelarabine may interact with other drugs that affect the nervous system or blood cell production. Combining it with certain chemotherapy agents or immunosuppressants could increase side effects. Alcohol and grapefruit products may also interact, so consult a healthcare provider before use.

References

Frequently Asked Questions

Nelarabine is used to treat certain types of cancer, including T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Atriance 50ml is administered intravenously by healthcare professionals in a clinical setting.

Common effects may include fatigue, changes in blood cell counts, or gastrointestinal discomfort.

Nelarabine is a prescription medication and should only be obtained through licensed pharmacies with a valid prescription.

Store nelarabine as directed by your healthcare provider, typically in a controlled environment away from light and moisture.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.